Brentuximab vedotin: targeting CD30 as standard in CTCL.

Brentuximab vedotin: targeting CD30 as standard in CTCL. Oncotarget. 2018 Feb 23;9(15):11887-11888 Authors: Prince HM, Gautam A, Kim YH PMID: 29552279 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research